The Effects of Information Displays in Decision About Tamoxifen Use for Breast Cancer Chemoprevention
Abstract
Behavioral interventions have focused primarily on early detection rather than the prevention of breast cancer; this trend is changing rapidly as chemoprevention agents, such as Tamoxifen, receive more attention. An important challenge is how to facilitate the review of Tamoxifen information among higher risk women who may benefit form its use. A second challenge is to understand how the format of conveying Tamoxifen's risks and benefits to affects women's (a) overall weighing of risk and benefits and (b) intentions use Tamoxifen. Whether a woman reviews information on Tamoxifen depends, in part, on how she interprets her BC risk. The purpose of this study is to test how the numerical format of conveying breast cancer (BC) risk and the risks and benefits of taking Tamoxifen as a chemopreventive agent individually and jointly affect women's intentions to sue Tamoxifen and talk to a health care provider about its use. Evaluating the effects of different formats, and understanding the psychosocial mechanisms through which they affect decision-making, will become increasingly important as more women consider Tamoxifen, other breast cancer chemopreventive agents (e.g., Raloxifen), and chemopreventive drugs for cancer more broadly.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jun 01, 2004
- Accession Number
- ADA425678
Entities
People
- Isaac Lipkus
Organizations
- Duke University